Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 14, 2021 - Issue
Submit an article Journal homepage
247
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy

Zhiqin Zhang1 Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan 430071, People’s Republic of ChinaView further author information
,
Lihua Ni1 Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan 430071, People’s Republic of ChinaView further author information
,
Lian Zhang1 Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan 430071, People’s Republic of ChinaView further author information
,
Dongqing Zha1 Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan 430071, People’s Republic of ChinaView further author information
,
Chun Hu1 Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan 430071, People’s Republic of ChinaView further author information
,
Lingli Zhang1 Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan 430071, People’s Republic of ChinaView further author information
,
Huiling Feng1 Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan 430071, People’s Republic of ChinaView further author information
,
Xiaobao Wei1 Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan 430071, People’s Republic of ChinaView further author information
&
Xiaoyan Wu1 Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan 430071, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 227-240 | Published online: 18 Jan 2021

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Meiyuan Dong, Huiling Chen, Song Wen, Yue Yuan, Liling Yang, Yanyan Li, Xinlu Yuan, Dongxiang Xu & Ligang Zhou. (2023) The Neuronal and Non-Neuronal Pathways of Sodium-Glucose Cotransporter-2 Inhibitor on Body Weight-Loss and Insulin Resistance. Diabetes, Metabolic Syndrome and Obesity 16, pages 425-435.
Read now
Ziyuan Zhang, Yaling Hu, Wenyuan Liu, Xiaodong Zhang, Ruihua Wang, Hui Li, Dalin Sun & Jingai Fang. (2022) Yishen Capsule Alleviated Symptoms of Diabetic Nephropathy via NOD-like Receptor Signaling Pathway. Diabetes, Metabolic Syndrome and Obesity 15, pages 2183-2195.
Read now

Articles from other publishers (11)

Lulu Zhang, Xiuteng Zhou, Huijian Chen, Liangzhen You, Ting Zhang, Meng Cheng, Yudi Yao, Xin Pan & Xinzhou Yang. (2023) Mulberry extract ameliorates T2DM-related symptoms via AMPK pathway in STZ-HFD-induced C57BL/6J mice. Journal of Ethnopharmacology 313, pages 116475.
Crossref
Ming Yang, Shilu Luo, Wei Chen, Li Zhao & Xi Wang. (2023) Chaperone-Mediated Autophagy: A Potential Target for Metabolic Diseases. Current Medicinal Chemistry 30:16, pages 1887-1899.
Crossref
Raysa S. Farias, Rodrigo P. Silva-Aguiar, Douglas E. Teixeira, Carlos P. Gomes, Ana Acacia S. Pinheiro, Diogo B. Peruchetti & Celso Caruso-Neves. (2023) Inhibition of SGLT2 co-transporter by dapagliflozin ameliorates tubular proteinuria and tubule-interstitial injury at the early stage of diabetic kidney disease. European Journal of Pharmacology 942, pages 175521.
Crossref
Moein Ala. (2023) Sestrin2 Signaling Pathway Regulates Podocyte Biology and Protects against Diabetic Nephropathy. Journal of Diabetes Research 2023, pages 1-15.
Crossref
Baris Afsar & Rengin Elsurer Afsar. (2022) Sodium–glucose cotransporter inhibitors and kidney fibrosis: review of the current evidence and related mechanisms. Pharmacological Reports 75:1, pages 44-68.
Crossref
Peiyang Song, Tianyi Chen, Shunli Rui, Xiaodong Duan, Bo Deng, David G. Armstrong, Yu Ma & Wuquan Deng. (2022) Canagliflozin promotes osteoblastic MC3T3-E1 differentiation via AMPK/RUNX2 and improves bone microarchitecture in type 2 diabetic mice. Frontiers in Endocrinology 13.
Crossref
Jain Siddhi, Bhoomika Sherkhane, Anil Kumar Kalavala, Vijay Arruri, Ravichandiran Velayutham & Ashutosh Kumar. (2022) Melatonin prevents diabetes‐induced nephropathy by modulating the AMPK/SIRT1 axis: Focus on autophagy and mitochondrial dysfunction. Cell Biology International 46:12, pages 2142-2157.
Crossref
Milton Packer. (2022) Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis. Circulation 146:18, pages 1383-1405.
Crossref
Xiaohu Wang, Qin Li, Bangzhi Sui, Maodi Xu, Zhichen Pu & Teng Qiu. (2022) Schisandrin A from Schisandra chinensis Attenuates Ferroptosis and NLRP3 Inflammasome-Mediated Pyroptosis in Diabetic Nephropathy through Mitochondrial Damage by AdipoR1 Ubiquitination. Oxidative Medicine and Cellular Longevity 2022, pages 1-23.
Crossref
Maliheh Entezari, Danial Hashemi, Afshin Taheriazam, Amirhossein Zabolian, Shima Mohammadi, Farima Fakhri, Mehrdad Hashemi, Kiavash Hushmandi, Milad Ashrafizadeh, Ali Zarrabi, Yavuz Nuri Ertas, Sepideh Mirzaei & Saeed Samarghandian. (2022) AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation. Biomedicine & Pharmacotherapy 146, pages 112563.
Crossref
Lihua Ni & Cheng Yuan. (2021) The Mitochondrial-Associated Endoplasmic Reticulum Membrane and Its Role in Diabetic Nephropathy. Oxidative Medicine and Cellular Longevity 2021, pages 1-11.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.